Walsh Jeffrey T.

Avg. Two Year Performance

No purchase track record
27% Avg. Sale Return
13% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(5%)(8%)(11%)15%27%
Sale Success Rate22 of 4620 of 4619 of 4628 of 4620 of 46
Drugs » Biotechnology

Chief Strategy Officer:

Holdings: 40.92K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--